Atossa Therapeutics

ATOS · NASDAQ

$2.54−$0.02 (−0.78%)TodayMarket closed ·
Prev close $2.56

Who owns ATOS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 16.6% of ATOS’s shares.

  • Heights Capital Management, Inc.3.8%
  • Vanguard Capital Management, LLC3.6%
  • Columbia Threadneedle Investments (US)2.6%
  • BlackRock Institutional Trust Company, N.A.1.6%
  • Next 6 largest institutions5.0%
  • All other shareholders83.4%
Top institutional holders of ATOS
HolderShares% of shares
Heights Capital Management, Inc.377.50K3.79%
Vanguard Capital Management, LLC361.75K3.63%
Columbia Threadneedle Investments (US)258.23K2.59%
BlackRock Institutional Trust Company, N.A.162.37K1.63%
Renaissance Technologies LLC132.04K1.32%
Geode Capital Management, L.L.C.92.38K0.93%
UBS Financial Services, Inc.82.62K0.83%
Quay (Steven C)67.41K0.68%
Daniel (Mark James CPA)63.00K0.63%
Jane Street Capital, L.L.C.56.60K0.57%

Largest mutual fund holders

Top mutual fund holders of ATOS
HolderShares% of shares
Vanguard Total Stock Market Index Fund256.14K2.57%
Columbia Small Cap Value Discovery Fund201.43K2.02%
Vanguard Extended Market Index Fund99.07K0.99%
Fidelity Extended Market Index Fund44.97K0.45%
Columbia Var Port Small Cap Value Discovery Fd35.78K0.36%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of ATOS in the last 6 months.

Latest ATOS insider transactions
InsiderTypeSharesValue
Chen Shu-ChihAward10.00K—
Remmel H. LawrenceAward10.00K—
Finn JonathanAward10.00K—
Galli Stephen JAward10.00K—
Cigler TessaAward10.00K—
Steinhart Richard IAward10.00K—

Short interest

Settled Sep 30, 2026

Shares short
788.33K
Days to cover
11.31
% of shares outstanding
7.91%
Average daily volume
69.72K
Change since last report
+3.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.